There is a low but increased risk of optic nerve disorders in patients with type 2 diabetes prescribed semaglutide or ...

Study: Semaglutide or Tirzepatide and Optic Nerve and Visual Pathway Disorders in Type 2 Diabetes. Image credit: Vince Scherer/Shutterstock.com A study published in JAMA Network Open reported that ...

About The Study: In this study of patients with type 2 diabetes who had no prior eye disorders, patients prescribed semaglutide or tirzepatide had an increased risk of nonarteritic anterior ...

Definitive conclusions regarding the association between semaglutide and nonarteritic anterior ischemic optic neuropathy ...

In recent years, GLP-1 receptor agonists such as semaglutide (Ozempic) and tirzepatide (Mounjaro) have garnered significant attention for their remarkable benefits in managing diabetes and promoting ...

Visual acuity was generally normal in spite of gross visual field constriction. Conclusion: We believe that VGB should be used with great caution where there is pre-existing visual pathway damage.

Incoming information from the retina is channeled into two pathways in the brain's visual system: one that's responsible for processing color and fine spatial detail, and another that's involved ...